Posted inPharmaceutical Industry News
Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
n n n By Ed SilvermanApril 28, 2026 n Pharmalot Columnist, Senior Writer n n…
Posted inPharmaceutical Industry News
Seaport and Hemab target $180m IPOs as biotech listings accumulate – Pharmaceutical Technology
n Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus…
Posted inPharmaceutical Industry News
Cellenkos receives FDA approval for CK0801 Phase II clinical trial
n The study will include patients refractory to prior therapy or intolerant to standard treatments.nn…
Posted inPharmaceutical Industry News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
nGood morning. The other night I watched a shocking episode of “The Vampire Diaries.†A series…
Posted inPharmaceutical Industry News
Merck KGaA and Remepy join forces to develop combo drug-digital therapies – Pharmaceutical Technology
n The pair will develop drug-digital therapeutic combinations as a singular product, thus sidestepping reimbursement…
Posted inPharmaceutical Industry News
Veradermics’ stock grows on pivotal hair loss win
n If approved, VDPHL01 could become the first hair loss drug to secure the regulatory…